Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Anemia and renal failure (RF) are related to poor prognosis in chronic heart failure (HF). Anemia appear early in the course of RF and its value as predictor of risk in HF may be overlap by the value of RF. We aimed to establish the prognostic value of anemia and RF in a Brazilian HF population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2008.11.089 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Safety Profile of Belzutifan in Renal Tumors: Real-World Data from a Tertiary Academic Center.
Oncologist
September 2025
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: Belzutifan is a HIF-2ɑ inhibitor approved for the treatment of tumors in von Hippel-Lindau (VHL) syndrome and sporadic metastatic clear cell renal cell carcinoma (spRCC) in the refractory setting. The efficacy and side effects of belzutifan are well-documented from clinical trials, however, real-world data examining the incidence and management of adverse events (AEs) are lacking. Our study aims to describe the AE profiles of belzutifan in spRCC and VHL populations.
View Article and Find Full Text PDFThe Safety and Efficacy of Daprodustat for Recipients in Peritransplant Period: a Single-Center Retrospective Study on Post-Transplant Anemia Management in Kidney Transplantation.
Transpl Int
August 2025
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Dedifferentiated Liposarcoma of the Kidney: Surgical Management and Diagnostic Insights.
Cureus
August 2025
Department of Surgery, Ayub Medical College, Abbottabad, PAK.
This report presents the case of a 62-year-old male who presented with a two-month history of right flank pain and decreased appetite. Clinical evaluation revealed a palpable, non-tender mass in the right flank, while laboratory tests demonstrated mild anemia (hemoglobin 9.3 g/dL) with otherwise normal renal function.
View Article and Find Full Text PDFFactors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer.
Open Med (Wars)
August 2025
Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, P. R. China.
Background: Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum of IPC remain incompletely understood. This study aimed to evaluate the incidence of hematologic and biochemical adverse reactions following surgery with or without IPC and to compare the toxicity profiles of normothermic IPC and HIPEC.
View Article and Find Full Text PDFClinical Significance, Differential Diagnosis and Initial Management of Hematuria in Emergency and Outpatient Settings.
Cureus
September 2025
Department of Urology, Janusz Korczak Provincial Specialist Hospital, Slupsk, POL.
Hematuria is a common clinical symptom that may reflect a wide spectrum of underlying conditions, ranging from benign etiologies to potentially life-threatening diseases such as urothelial carcinoma or renal trauma. It is generally classified as either gross (visible) or microscopic (detected only through urinalysis), and particularly in emergency settings, it requires prompt and structured evaluation to guide further diagnostic and therapeutic decisions. Delayed recognition may result in missed malignancies or avoidable complications, underscoring the importance of early and accurate assessment at the initial point of medical contact.
View Article and Find Full Text PDF